Daniel works with the CAPDM Board of Directors to strengthen the association’s position as the authoritative voice representing Canada’s pharmacy supply chain. He is an advocate for CAPDM from coast to coast on government and regulatory issues that impact its membership. Daniel leads a CAPDM team that delivers premium member services and fosters member engagement.
Daniel is a senior executive with supply chain expertise and proven leadership in driving growth, profitability, and collaboration within the healthcare and food & beverage industry sectors. Prior to joining CAPDM, Daniel served as Vice President, Supply Solutions at McKesson Canada. Daniel has held senior executive roles at Shoppers Drug Mart, Cardinal Health Canada and MDS Inc.
Daniel holds a Master of Business Administration degree, from the Ivey School of Business at the University of Western Ontario, and a B. Mgmt. Sc., from the University of Ottawa.
Day 1: Oct 6, 2020
Day 2: Oct 7, 2020
Day 3: Oct 8, 2020
Keynote Panel Discussion:
Inform your Market Access Strategy with Cross-Border Perspectives on CUSMA, Affordable Drug Prices and Access to Prescription Medicine during Covid-19 and Beyond
One of the consequences of Covid-19 is the problem many people have accessing prescription medication in both Canada and the U.S. because of unemployment and escalating drug costs. Both Canada and the U.S. have taken steps to address rising costs, so far with limited success. CUSMA will also have an impact on access going forward. Gain key insights on:
- The impact CUSMA may have on IP and Canada’s listing on the ‘Watch List’ of the Office of the U.S. Trade Representative
- Canada’s future prospects of gaining access to vaccines for Covid-19
- Progress of drug price containment initiatives of both Canada and the U.S.
Sharpen your North American market access strategies with key insights on cross-border issues